BFC Planning’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.21M Sell
50,440
-12,198
-19% -$302K 0.05% 344
2026
Q2
$1.58M Sell
62,638
-731
-1% -$18.4K 0.06% 288
2026
Q1
$1.6M Buy
63,369
+8,208
+15% +$209K 0.07% 266
2025
Q4
$1.41M Buy
55,161
+1,916
+4% +$49K 0.06% 286
2025
Q3
$1.36M Buy
53,245
+8,633
+19% +$219K 0.1% 186
2025
Q2
$1.13M Buy
44,612
+9,533
+27% +$237K 0.09% 202
2025
Q1
$877K Buy
35,079
+1,208
+4% +$29.9K 0.08% 224
2024
Q4
$833K Buy
33,871
+9,594
+40% +$240K 0.07% 227
2024
Q3
$624K Buy
+24,277
New +$613K 0.05% 290

Other funds holding IBDX

BFC Planning's IBDX Position: Q3 2026 in Review

BFC Planning reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 19% in Q3 2026, selling an estimated $302K and leaving 50,440 shares worth $1.21M. The position accounts for 0.05% of the portfolio, ranked #344.

BFC Planning first reported a position in IBDX in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.6M in Q1 2026. 218 funds tracked by Wall St. Rank hold IBDX as of Q3 2026.

  • BFC Planning held 50,440 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.21M as of Q3 2026.
  • BFC Planning sold 12,198 iShares iBonds Dec 2032 Term Corporate ETF shares in Q3 2026, an estimated $302K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.05% of BFC Planning's portfolio in Q3 2026, its #344 holding.
  • BFC Planning first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $1.6M in Q1 2026.
  • 218 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.